Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Expected turn with unexpected news. Good day for RXMD$$
Don't forget ladies and gentleman, if you have added to up the shares in those GTC sell orders you have out there for $1.00
By millions, how many do you think.
According to my previous calculations using T-trades, the max is 8-9 million shares to pay off roughly $80-90K.
Imprimis Pharmaceuticals (Nasdaq: IMMY) is a pharmaceutical company dedicated to delivering high quality and innovative medicines to physicians and patients at affordable prices. We are pioneering a new commercial pathway in the pharmaceutical industry, using compounding pharmacies for the formulation and distribution of high quality, proprietary formulations that are supported by the clinical experience of physicians and their patients. We are focused on ophthalmology, urology, and sinus drug therapies; however we also sell other formulations outside of our core therapeutic areas. All of our innovative drug formulations are born from the clinical experience of physician prescribers and pharmacist formulators. We believe our unique business model provides us with the opportunity to address unmet patient needs while delivering safe, near-term and affordable medical solutions to Americans.
Our vision is to deliver customized and other novel medicines to physicians and patients TODAY at accessible prices.
About Express Scripts
Express Scripts puts medicine within reach of tens of millions of people by aligning with plan sponsors, taking bold action and delivering patient-centered care to make better health more affordable and accessible.
Headquartered in St. Louis, Express Scripts provides integrated pharmacy benefit management services, including network-pharmacy claims processing, home delivery pharmacy care, specialty pharmacy care, specialty benefit management, benefit-design consultation, drug utilization review, formulary management, and medical and drug data analysis services. Express Scripts also distributes a full range of biopharmaceutical products and provides extensive cost-management and patient-care services.
For more information about Express Scripts, visit Lab.Express-Scripts.com or follow @ExpressScripts on Twitter.
About Imprimis Pharmaceuticals
San Diego-based Imprimis Pharmaceuticals, Inc. (IMMY) is a national leader in the development, production and dispensing of novel compounded pharmaceuticals. The company's business primarily consists of four therapeutic segments including ophthalmology, urology, sinus and integrative medicine. Imprimis dispenses compounded pharmaceuticals in all 50 states from four facilities located in California, Texas, New Jersey and Pennsylvania. For more information about Imprimis, visitwww.ImprimisPharma.com or follow @imprimispharma on Twitter. For additional information, please contact Bonnie Ortega, Director of Investor Relations, (858) 704-4587 or emailbortega@imprimispharma.com.
All Imprimis compounded formulations may only be prescribed pursuant to a physician prescription for an individually identified patient consistent with federal and state laws governing compounded drug formulations.
It would be more likely for him to buyout the company. Costing him money if I am reading this correctly!
By the way, I do have the ability to PM now.
And this wasn't even a PR we were expecting. Hands Down this is a great company to be a part of.
Liking this a lot!!. Maybe others have some more info or better knowledge regarding. Are we likely to be supplier for IMMY who is dealing with Express Scripts.
I guess whoever had the 400K and 2 million shares up yesterday changed their mind! Was it do to talk of yield sign possibly being removed in the near future? That's what remains great about RXMD, the DD done by individuals here and that it has so much upside potential here. We currently have a yield sign, haven't got audited financials yet, new contract revenues are in process, debt elimination PR, new region focus, and expansion is inevitable, all with a company expected to gross 15 million in revenue/year without new contracts and they are profitable.
Thanks golfboy, perfect timing for repost. Update on the news mentioned below shouldn't be too far out now.
Progressive Care Inc. Reports Positive Response From New York Road Show
8:01 am ET November 24, 2015 (Market Wire)
Progressive Care Inc. (OTC PINK: RXMD), through its subsidiary Pharmco LLC, a South Florida provider of prescription pharmaceuticals specializing in health practice risk management, the sale of anti-retroviral medications and related medication therapy management, the sale and rental of durable medical equipment ("DME") and the supply of prescription medications to long term care facilities, announces results from its recent non-deal road show in New York City.
Progressive Care presented the company late last week, showcasing the many milestones hit throughout the 2015-year. The road show participants were pleased with the ongoing development of the Company namely the establishment of the PharmCo brand, the improvements to its financial position, and the imminent completion of the 3(a)(10) transaction.
Shital Parikh Mars stated, "It was a very busy week in preparation for the deployment of this non-deal road show. This was the first road show the company has done and I'm happy to report that we received exceptionally favorable responses. It is just another testament to the company's goal of continuing to build real shareholder value through our current business model and we're looking forward to building a lasting relationship with the investment community."
In addition, the Company recently issued what it believes to be its final tranche of shares to Tarpon Bay for completion of its 3(a)(10) transaction. Progressive recently reported positive results from operations during the month of October and highlighted the increased demand from its compounding business. Management expects to provide an update during the first half of December on this month's operational performance as well as an update on the status of the 3(a)(10) transaction.
About Progressive Care
Progressive Care Inc. (OTC PINK: RXMD), through its subsidiary PharmCo, LLC, is a South Florida provider of prescription pharmaceuticals specializing in health practice risk management, the sale of anti-retroviral medications and related medication therapy management, the sale and rental of durable medical equipment and the supply of prescription medications to long term care facilities.
Cautionary Statement Regarding Forward Looking Statements
Statements contained herein that are not based upon current or historical fact are forward-looking in nature and constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Such forward-looking statements reflect the Company's expectations about its future operating results, performance and opportunities that involve substantial risks and uncertainties. These statements include but are not limited to statements regarding the intended terms of the offering, closing of the offering and use of any proceeds from the offering. When used herein, the words "anticipate," "believe," "estimate," "upcoming," "plan," "target", "intend" and "expect" and similar expressions, as they relate to Progressive Care Inc., its subsidiaries, or its management, are intended to identify such forward-looking statements. These forward-looking statements are based on information currently available to the Company and are subject to a number of risks, uncertainties, and other factors that could cause the Company's actual results, performance, prospects, and opportunities to differ materially from those expressed in, or implied by, these forward-looking statements.
SOURCE: Progressive Care Inc.
That's exactly what we want around here. Make these idiots who are selling/flipping large chunks of shares to have to come down close to the bid so that the strong willed hands can gobble them up until news breaks that is.
If you have such confidence that it is going subpenny then why the need to post it. Shows a severe lack of confidence on your part. It goes both ways, only your "supposition" is based on a one year historical chart. Really, are you serious. What else you got, cmon, tell us.
Already have in 3 fold!
Yah, I really like my chances here. Let's say you acquire 2 million shares and hope to short from .014 to .008. That's $12,000 profit. Now lets say I acquire 2 million shares at $0.013 and sell at $.08, that's $134,000 profit. Good Luck with your not so bright trading path on an OTC! stock with actual revenues, sales, and profits. I repeat this isn't just pipe dreams of revenues and sales, they already have an established and profitable business.
Oh, you mean a couple of months ago when all of us longs were loading up on shares as they were obviously and knowing selling shares to pay off Tarpon debt. Way to predict a decline during dilution, YOU ARE THE BEST!! LOL Also longs were updating and reporting the debt balances on a weekly basis and acknowledging the gains in revenue, sales, and profits that this company has made and reported over the past year to provide sound DD to any potential investors. That's not pumping and hyping that's reality, this isn't your OTC garbage land stock.
Your comparing apples and oranges here obviously as this company is in different hands; generating record revenues, sales, and profits on a monthly basis; oh and debt free. But if you want to use the 1 year trend and your ridiculous supposition (who uses this word) then that means we are soon to hit $.08 which means big money for RXMD$$ investors. Don't leave off that part of the 1 year trend there buddy.
I turned around and slapped the ask for 200K with a limit of .0145 and it didn't budge off of .0132
Thanks, I am ecstatic to be able to load up some more at these levels. Kept some dry powder handy too.
Hey fellas, that 900K is me, and they are apparently digging a mote around me, if things are hitting as you say and I am not getting any pieces of it. Take that back, finally a shred taken.
You like that bid support, it appears to have raised just a bit to .013! LOL
Doesn't hurt my feelings any! If it indeed is the final tranche of debt, it will be done quicker with much less shares issued to pay it off.
Is that with or without 25% fee?
Might I suggest keeping a little dry powder on the side. Going to acquire shares using about 75% of funds and then keep 25% free for runs.
Personally, I have not sold one single share of RXMD and I started buying about 6 months ago or so when it was retreating from the $0.08. I hold millions of shares and for me the little flips performed hurt when the price of the stock is heading up and when a long such as myself may be slapping the ask just wasted that powder to take out an unnecessary lot of shares put up for sale by a fellow long. Also, did that little flip hurt or help the pps of the entire lot of shares you still hold?
Food for thought. Go with your gut I suppose. To each their own in trade strategy. Happy Thanksgiving to all.
Wow some people just gave away some free shares. Did you get yours picked up today? Nice day for it.
Meet you at the finish line!! LOL
That was going to be my same approach come Friday.
He is definitely referring to the 340B contract likely to have begun this month or next.
Let's go RXMD$$
Yah, I am looking to accumulate another million shares here. By the time money frees up though, it may be less than a million at this rate. I hate 3 day wait periods. Dammit.
Friday for me.
I think this is a different bird though, not just an update on remaining balance. Pay off, should be sooner, hopefully. Also, we haven't got an update for October yet, which usually is out by now, so maybe they knew we were close and decided to wait it out.
Just put your poor short shares up for sell this week, I will gladly buy your ass out.
You buy the beer, I will buy the truck they transport your beer in.
Going to free up some more funds for additional investment in this one. Like the potential here.
That would be nice, but I am fine with slow and steady 25% gains/day here. No 50%/day gains required.
I am solid here, looking for much much more out of this company. So much to come yet from them.
Wish there were 5 more stocks like this one out there, or I just wish I had 5 times as many shares. Nice seeing green under RXMD position.
These price levels are just a right of passage. Oh and yah we still have a yield sign, it can be seen both ways here boys and girls, when that gets cleared (which management is adamant on fulfilling now that business structure is solid), well I will let you imagine.
Well Trillmoney,
Glad you did you DD here, I am sure you will get more great info from other longs here, but we think the debt may have finally been eliminated yesterday at just around noon. The debt holder's MM (BKRT) backed off all the way to .05, and most longs doing their fast amount of DD felt like we close based on trade knowledge since the 10Q came out showing that only $527 was left as of 9/30/15. So we either think that it's completely settled and we are waiting for a PR to confirm, or there may be just about another 10 million shares at most to be sold to settle it. The previous was just a statement to stay conservative on the debt, but the longs do feel it has been settled when a big 7.1 million trade hit in an instant yesterday and BKRT cleared the path. No additional debt of this type has been communicated, only maybe some traditional bank financing for expansion of facility and robots for dispensing prescriptions is all that has been mentioned thus far. Which none of which will be toxic like the convertible debt that has been eliminated.
We can start with the fact that at present they will have 15 million in revenues for the calendar year and now earning gross profit with over 16000 prescription fills a month, with expectation of 20,000 by end of this calendar year. In addition to the fact that they just paid off 2.4 million in start-up debt in less than a year. At present 15 million in revenues a year and now earning gross profit with over 16,000 prescription fills a month, with expectation of 20,000 by end of this calendar year. Also, they have every intent on beginning to file with SEC, just wanted to get business in top shape first, before pursuing those additional costs. You can check the ARMEN Conversation sticky for that info.